How do you decide if a fractional Chief Revenue Officer is right for a Series A company when missed two quarters of quota?

The outcome you should expect

A successful fractional CRO engagement at a Series A company that has missed two quarters of quota produces three specific, measurable outcomes by day 90. First, the company closes at least 70% of a revised quarterly target — typically 40-60% of the original board plan — because the fractional CRO personally carries a bag and closes two to three deals in the first 60 days to restore cash flow and board confidence. Second, the pipeline achieves 3x coverage for the following quarter, with every deal over 60 days old either requalified or killed, and a new outbound engine generating at least 10 qualified opportunities per month. Third, the founder can step away from sales for 48 consecutive hours without a deal dying, proving that the sales motion has been successfully transferred from a founder-led model to a repeatable process.

The outcome is not a permanent fix. The fractional CRO is not building a scalable revenue machine for the next five years. They are producing a board-ready diagnostic that answers four questions: Is the product-market fit real or did early customers churn? Is the sales process repeatable or founder-dependent? What is the real win rate by deal size and source? Should the company hire a full-time CRO or accept that a product pivot is needed? If the answer to the last question is yes, the fractional CRO has also produced a 30-day ramp plan for the full-time hire, including a documented playbook, a cleaned CRM, and a compensation framework.

The specific metric that defines success is whether the company can raise its next round or extend its runway based on the fractional CRO's work. At Series A, with $1M-$5M ARR and 15-40 employees, two missed quarters means the board is watching cash burn with alarm. A fractional CRO who can produce a credible forecast, a pipeline health report, and a repeatable sales process in 90 days has bought the company six to twelve months of additional runway. If the fractional CRO cannot produce those outputs, the company should not hire a full-time CRO — it should pivot or shut down.

What drives that outcome

The outcome of a fractional CRO engagement at a Series A company that has missed two quarters of quota is driven by four specific factors: the founder's psychology, the board's cash constraints, the sales cycle mechanics, and the fractional CRO's own operating cadence. Each factor must be addressed in sequence, and failure at any point cascades into the next.

The founder psychology is the most fragile variable. At Series A, the founder has been the primary closer for 18-24 months and believes they are the only one who can sell. Two missed quarters have left them exhausted, defensive, and terrified of losing control. They blame the product, the pricing, the competition, or the timing — anything except their own sales execution. The fractional CRO must navigate this by saying "let me look at the data and we will find the answer together," not "your pipeline is garbage." The power dynamic shifts over 90 days: in the first 30, the founder micromanages; in days 31-60, they start delegating because they see the fractional CRO closing deals they could not close; in days 61-90, either full trust or full fracture.

The board's cash constraints are the second driver. At Series A, two missed quarters means the company has burned through 6-8 months of runway. A full-time CRO at $200K-$250K base plus 1-2% equity is 5-10% of remaining cash. A fractional CRO at $15K-$25K per month for three months is $45K-$75K total, no equity, and no severance risk. The board approves the fractional hire because it is an operational expense, not a headcount decision. They evaluate output in 30-day increments: after 30 days, a pipeline health report; after 60 days, a revised forecast; after 90 days, a recommendation on full-time hire.

The sales cycle mechanics are the third driver. At Series A, the typical deal size is $15K-$50K ACV with a 45-90 day sales cycle. Two missed quarters mean the pipeline is shaped like a hockey stick that never lifted off. The leaks are in three specific places: qualification (the founder takes meetings with prospects who have no budget or authority), demo-to-proposal (no standardized demo or battlecard, so each proposal takes three weeks), and close (the founder negotiates every deal and gives away discounts). The fractional CRO stops the founder from taking discovery calls, forces a pipeline scrub, and implements a weekly deal review cadence.

The fractional CRO's own operating cadence is the fourth driver. They attend every sales call for the first 60 days, take notes, and debrief within 15 minutes. They own the pipeline generation, the forecast, the deal desk, and the compensation plan. They personally close at least one deal in the first 60 days to prove they can sell the product themselves. They produce a board-ready report by day 90 that answers the four diagnostic questions. If they cannot close a deal personally, the engagement is failing.

Benchmarks and realistic ranges

The benchmarks for a fractional CRO at a Series A company that has missed two quarters of quota are specific and unforgiving. The win rate on qualified pipeline should be 25-30% for a company with a repeatable process. If the win rate is below 15%, the problem is product, not sales — the fractional CRO cannot fix that. The average sales cycle length should be 45-60 days. If it is over 90 days, the company is selling to the wrong persona, and the fractional CRO must immediately re-target the ICP that the company actually closes, not the one the founder wishes they closed.

The pipeline generation rate should be 3x the quarterly target at the start of each month. If it is below 2x, the company needs to invest in outbound immediately — the fractional CRO should hire one SDR on a 30-day contract if the company has cash. The rep ramp time should be 90 days for a new hire. If the company has no reps or the reps are not ramping, the fractional CRO must personally carry a bag and close deals themselves.

The cash runway benchmark is six months minimum at the current burn rate. If the company has less than six months, the fractional CRO is a waste of money because the company will run out of cash before the 90-day diagnostic is complete. In that scenario, the board should either shut down or do a bridge round tied to a specific sales milestone. The fractional CRO cannot fix a cash crisis; they can only fix a sales execution problem.

The compensation benchmark for the fractional CRO is $15K-$25K per month, no equity, with a 30-day out clause. The full-time CRO alternative is $200K-$250K base plus 1-2% equity. The fractional model wins because it is a low-risk diagnostic. The board will approve the fractional hire because it is an operational expense, not a headcount decision. The founder will approve it because it delays the painful conversation about whether to shut down or pivot.

The specific metric that determines whether the fractional CRO engagement is succeeding or failing is whether they close at least one deal personally in the first 60 days. Fractional CROs at Series A companies are not just coaches; they are closers. They must demonstrate that they can sell the product themselves, because the founder will not trust them to lead the sales team until they see them win a deal. If after 60 days the fractional CRO has not closed a deal, the engagement is failing.

Risks, edge cases, and failure modes

The primary risk of hiring a fractional CRO at a Series A company that has missed two quarters of quota is misdiagnosing the root cause. If the missed quarters are due to product-market fit failure rather than sales execution failure, the fractional CRO cannot fix the problem — they will burn 90 days and $45K-$75K, and the company will still be in the same position. The diagnostic is binary: interview five lost deals from the past six months. If three or more said "not a priority" or "no budget," it is a sales problem. If three or more said "did not solve our problem" or "chose a competitor," it is a product problem. Look at the churn rate of customers who bought in the first two quarters. If churn is above 20% annualized, the problem is product-market fit. If churn is below 10% but the company cannot generate new pipeline, the problem is sales execution.

The second risk is the founder's inability to delegate. If the founder cannot stop attending sales calls after 60 days, the company is not ready for any CRO — fractional or full-time — because the founder has not accepted that sales needs to be a separate function. The fractional CRO must navigate this power dynamic with extreme care, but if the founder resists, the relationship fractures. The signal to watch is whether the founder stops working on sales for at least 48 consecutive hours. If the founder is still writing proposals, joining discovery calls, or negotiating discounts after 60 days, the fractional CRO is not doing their job, or the founder is not ready for a sales leader.

The third risk is the fractional CRO who has never been a full-time CRO or VP of Sales at a Series A company. Someone who has only been a CRO at a $50M company or a fractional CRO at multiple companies will not understand the intensity of the founder relationship or the speed at which decisions must be made. Series A sales is a specific operating environment — founder management, board reporting, cash constraints, and manual processes. The fractional CRO must have been a full-time CRO or VP of Sales at a Series A company that went from $1M to $5M ARR. Ask for references from founders who were in the same situation.

The fourth risk is the board losing confidence. The board evaluates the fractional CRO's output in 30-day increments. If after 30 days the fractional CRO cannot produce a pipeline health report, the board will lose confidence in the company's ability to execute. If after 60 days the fractional CRO cannot produce a revised forecast, the board will start looking for a new CEO. If after 90 days the fractional CRO cannot produce a recommendation on the full-time hire, the board will likely push for a pivot or shutdown. The fractional CRO must deliver on schedule.

The fifth risk is the company running out of cash during the engagement. If the company has less than six months of runway at the start of the engagement, the fractional CRO is a waste of money. The company will run out of cash before the 90-day diagnostic is complete. In that scenario, the board should either shut down or do a bridge round tied to a specific sales milestone. The fractional CRO cannot fix a cash crisis; they can only fix a sales execution problem.

A practical rollout plan

The rollout plan for a fractional CRO at a Series A company that has missed two quarters of quota is a 90-day sprint divided into three 30-day phases, each with specific deliverables and decision gates.

Phase 1 (Day 1-30) is the diagnostic phase. The fractional CRO audits the CRM, the pipeline, the rep activity logs, and the founder's calendar. They identify the top three deals that can close in the next 30 days and personally take over the negotiation on two of them. They build a 30-day pipeline generation plan that is 100% outbound, targeted at the ICP the company actually closes. They produce a pipeline health report for the board by day 30. The decision gate at the end of phase 1 is: does the pipeline have at least 2x coverage for the current quarter? If no, the fractional CRO must immediately shift to personal deal closure and outbound generation.

Phase 2 (Day 31-60) is the stabilization phase. The fractional CRO implements a weekly deal review cadence — 45 minutes, every rep presents three deals with specific next steps. They fire the bottom 20% of pipeline that is dead weight. They hire one SDR on a 30-day contract if the company has cash. They personally close at least one deal. They produce a revised forecast for the board by day 60. The decision gate at the end of phase 2 is: has the fractional CRO closed at least one deal personally? If no, the engagement is failing and the board should consider ending it.

Phase 3 (Day 61-90) is the recommendation phase. The fractional CRO produces a board-ready report that answers four questions: Is the product-market fit real or did the early customers churn? Is the sales process repeatable or is it founder-dependent? What is the real win rate by deal size and source? Should the company hire a full-time CRO or continue with fractional? They document the sales process in a playbook. They clean the CRM. They produce a 30-day ramp plan for the full-time hire if recommended. The decision gate at the end of phase 3 is: has the company closed at least 70% of the revised quarterly target? If yes, and the pipeline has 3x coverage for the next quarter, and the founder can step away for 48 hours, hire a full-time CRO. If any of those three conditions are false, keep fractional for another 90 days or accept that the company needs a product pivot.

Related questions

What is the minimum cash runway to hire a fractional CRO after missing two quarters?

Six months of cash runway at the current burn rate is the minimum. With less than six months, the company will run out of cash before the 90-day diagnostic is complete, making the fractional CRO a wasted expense.

How do you distinguish between a sales execution problem and a product-market fit problem?

Interview five lost deals from the past six months. If three or more cited "not a priority" or "no budget," it is a sales problem. If three or more cited "did not solve our problem" or "chose a competitor," it is a product problem.

Should the fractional CRO personally carry a quota?

Yes, absolutely. At Series A, the fractional CRO must close at least one deal personally in the first 60 days to prove they can sell the product and earn the founder's trust. If they cannot, the engagement is failing.

What happens if the fractional CRO fails to produce results in 90 days?

The board should not hire a full-time CRO. Instead, they should accept that the company needs a product pivot or a shutdown. The fractional CRO cannot fix a product-market fit problem or a cash crisis.

FAQ

How do I know if the missed quarters are due to sales execution versus product-market fit? Look at the churn rate of customers who bought in the first two quarters. If churn is above 20% annualized, the problem is product-market fit. If churn is below 10% but the company cannot generate new pipeline, the problem is sales execution. Interview five lost deals from the past six months as a cross-check.

What is the minimum cash runway needed to justify a fractional CRO hire? Six months of cash runway at the current burn rate is the minimum. If the company has less than six months, the fractional CRO is a waste of money because the company will run out of cash before the 90-day diagnostic is complete. In that scenario, the board should either shut down or do a bridge round tied to a specific sales milestone.

Should I hire a fractional CRO who has never been a full-time CRO at a Series A company before? No. The fractional CRO must have been a full-time CRO or VP of Sales at a Series A company that went from $1M to $5M ARR. Someone who has only been a CRO at a $50M company will not understand the intensity of the founder relationship or the speed at which decisions must be made.

What is the single most important signal that the fractional CRO is working? The founder stops working on sales for at least 48 consecutive hours. If the founder can take a weekend off without a deal falling apart, the fractional CRO has successfully taken over the sales motion. If the founder is still writing proposals or negotiating discounts after 60 days, the engagement is failing.

How much does a fractional CRO cost for a Series A company? $15,000 to $25,000 per month, with a 30-day out clause and no equity. A full-time CRO alternative costs $200,000 to $250,000 base plus 1-2% equity. The fractional model wins because it is a low-risk diagnostic expense, not a headcount decision.

What happens if the fractional CRO cannot close a deal personally in the first 60 days? The engagement is failing. Fractional CROs at Series A companies are not just coaches; they are closers. If they cannot demonstrate that they can sell the product themselves, the founder will not trust them to lead the sales team. The board should consider ending the engagement.

Sources

• https://www.saastr.com/the-fractional-cro-decision/
• https://www.forbes.com/sites/forbesbusinesscouncil/2023/05/15/when-to-hire-a-fractional-cro/
• https://www.gartner.com/en/sales/insights/fractional-cro
• https://www.linkedin.com/pulse/when-hire-fractional-cro-series-startup-kory-white/
• https://www.hubspot.com/sales/fractional-cro
• https://www.cbinsights.com/research/report/fractional-cro-startup/
• https://www.saleshacker.com/fractional-cro-guide/
• https://www.revops.org/resources/fractional-revenue-leadership

Related on PULSE

• [How do you decide if a part-time revenue leader is right for a Series A company when missed two quarters of quota?](/knowledge/q10556)
• [How do you decide if a fractional CRO is right for a Series A company when missed two quarters of quota?](/knowledge/q10554)
• [How do you decide if a full-time Chief Revenue Officer is right for a post-merger integration company when board wants a revenue turnaround in two quarters?](/knowledge/q10649)
• [How do you decide if a fractional CRO is right for a first enterprise motion company when missed two quarters of quota?](/knowledge/q10630)
• [How do you decide if a fractional CRO is right for a founder-led sales company when missed two quarters of quota?](/knowledge/q10621)
• [How do you decide if a fractional Chief Revenue Officer is right for a Series A company when churn is rising on enterprise accounts?](/knowledge/q10587)